Source: BioPortfolio

Eternygen: Eternygen GmbH Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 09032018 Prices from USD $250

SummaryEternygen GmbH Eternygen focuses on research and development of innovative drugs for dietaryrelated metabolic diseases.The company's product development portfolio includes novel small molecule inhibitors developed against the sodium coupled citrate...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Marco Janezic's photo - Founder & CEO of Eternygen

Founder & CEO

Marco Janezic

CEO Approval Rating

88/100

Read more